Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study, With Expanded Cohort, of Biweekly Fixed-dose Rate Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic and Biliary Carcinomas

NCT00626158 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00626158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00626158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study, With Expanded Cohort, of Biweekly Fixed-dose Rate Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic and Biliary Carcinomas
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2008
Completion date
December 31, 2010
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biliary cancer, pancreatic cancer